Health Catalyst Stock Revenue
| HCAT Stock | USD 4.45 0.31 7.49% |
Health Catalyst fundamentals help investors to digest information that contributes to Health Catalyst's financial success or failures. It also enables traders to predict the movement of Health Stock. The fundamental analysis module provides a way to measure Health Catalyst's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Health Catalyst stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 306.6 M | 226.9 M |
Health | Revenue |
Health Catalyst Company Revenue Analysis
Health Catalyst's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Health Catalyst Revenue | 306.58 M |
Most of Health Catalyst's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Health Catalyst is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Health
Projected quarterly revenue analysis of Health Catalyst provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Health Catalyst match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Health Catalyst's stock price.
Health Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Health Catalyst is extremely important. It helps to project a fair market value of Health Stock properly, considering its historical fundamentals such as Revenue. Since Health Catalyst's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Health Catalyst's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Health Catalyst's interrelated accounts and indicators.
| 0.97 | 0.96 | -0.02 | 0.7 | 0.67 | ||
| 0.97 | 1.0 | -0.12 | 0.67 | 0.73 | ||
| 0.96 | 1.0 | -0.12 | 0.63 | 0.73 | ||
| -0.02 | -0.12 | -0.12 | -0.14 | -0.71 | ||
| 0.7 | 0.67 | 0.63 | -0.14 | 0.66 | ||
| 0.67 | 0.73 | 0.73 | -0.71 | 0.66 |
Click cells to compare fundamentals
Health Revenue Historical Pattern
Today, most investors in Health Catalyst Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Health Catalyst's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Health Catalyst revenue as a starting point in their analysis.
Health Catalyst Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Health Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Health Catalyst reported 306.58 M of revenue. This is 95.98% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 96.75% higher than that of the company.
Health Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Health Catalyst's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Health Catalyst could also be used in its relative valuation, which is a method of valuing Health Catalyst by comparing valuation metrics of similar companies.Health Catalyst is currently under evaluation in revenue category among its peers.
Health Catalyst Current Valuation Drivers
We derive many important indicators used in calculating different scores of Health Catalyst from analyzing Health Catalyst's financial statements. These drivers represent accounts that assess Health Catalyst's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Health Catalyst's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 1.7B | 1.9B | 571.1M | 522.4M | 600.8M | 1.2B | |
| Enterprise Value | 1.8B | 1.9B | 702.7M | 665.2M | 765.0M | 1.2B |
Health Catalyst ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Health Catalyst's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Health Catalyst's managers, analysts, and investors.Environmental | Governance | Social |
Health Catalyst Institutional Holders
Institutional Holdings refers to the ownership stake in Health Catalyst that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Health Catalyst's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Health Catalyst's value.| Shares | Geode Capital Management, Llc | 2024-12-31 | 1.4 M | Bank Of New York Mellon Corp | 2024-12-31 | 1.4 M | Jpmorgan Chase & Co | 2024-12-31 | 1.2 M | State Street Corp | 2024-12-31 | 1.2 M | Goldman Sachs Group Inc | 2024-12-31 | 886.7 K | Portolan Capital Management, Llc | 2024-12-31 | 749 K | American Century Companies Inc | 2024-12-31 | 710.5 K | Nuveen Asset Management, Llc | 2024-12-31 | 593.6 K | Northern Trust Corp | 2024-12-31 | 526.6 K | Blackrock Inc | 2024-12-31 | 5.6 M | First Light Asset Management, Llc | 2024-12-31 | 5.2 M |
Health Fundamentals
| Return On Equity | -0.19 | ||||
| Return On Asset | -0.0457 | ||||
| Profit Margin | (0.23) % | ||||
| Operating Margin | (0.19) % | ||||
| Current Valuation | 322.7 M | ||||
| Shares Outstanding | 70.21 M | ||||
| Shares Owned By Insiders | 3.50 % | ||||
| Shares Owned By Institutions | 76.55 % | ||||
| Number Of Shares Shorted | 2.06 M | ||||
| Price To Earning | (2.62) X | ||||
| Price To Book | 0.86 X | ||||
| Price To Sales | 1.02 X | ||||
| Revenue | 306.58 M | ||||
| Gross Profit | 141.79 M | ||||
| EBITDA | (27.1 M) | ||||
| Net Income | (69.5 M) | ||||
| Cash And Equivalents | 403.35 M | ||||
| Cash Per Share | 7.37 X | ||||
| Total Debt | 251.09 M | ||||
| Debt To Equity | 0.53 % | ||||
| Current Ratio | 5.15 X | ||||
| Book Value Per Share | 5.70 X | ||||
| Cash Flow From Operations | 14.56 M | ||||
| Short Ratio | 2.82 X | ||||
| Earnings Per Share | (1.15) X | ||||
| Target Price | 8.42 | ||||
| Number Of Employees | 1.5 K | ||||
| Beta | 1.41 | ||||
| Market Capitalization | 312.44 M | ||||
| Total Asset | 858.93 M | ||||
| Retained Earnings | (1.19 B) | ||||
| Working Capital | 139.8 M | ||||
| Current Asset | 216.75 M | ||||
| Current Liabilities | 48.69 M | ||||
| Net Asset | 858.93 M |
About Health Catalyst Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Health Catalyst's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Health Catalyst using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Health Catalyst based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.